α-Haemolysin of Escherichia coli in IBD: A potentiator of inflammatory activity in the colon

Gut

Volumn 63, Issue 12, 2014, Pages 1893-1901

  Bücker, Roland ^a   Schulz, Emanuel ^a   Günzel, Dorothee ^b   Bojarski, Christian ^a   Lee, In Fah M ^b   John, Lena J ^a   Wiegand, Stephanie ^a   Janßen, Traute ^c   Wieler, Lothar H ^c   Dobrindt, Ulrich ^d   Beutin, Lothar ^e   Ewers, Christa ^f   Fromm, Michael ^b   Siegmund, Britta ^a   Troeger, Hanno ^a   Schulzke, Jörg Dieter ^a  

^a Infectious Diseases and Rheumatology ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ESCHERICHIA COLI PROTEIN; HEMOLYSIN; HLYA PROTEIN, E COLI;

ANIMAL; CROHN DISEASE; DISEASE MODEL; ELECTROPHYSIOLOGY; ESCHERICHIA COLI; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE CELL; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; MOUSE; MUCOSAL IMMUNITY; PATHOGENICITY; PATHOLOGY; PERMEABILITY; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGICAL PROCESSES; ENTEROCYTES; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HEMOLYSIN PROTEINS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; MICE; MICE, KNOCKOUT; PERMEABILITY;

EID: 84893835098     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306099     Document Type: Article

References (41)

1. Gradel KO, Nielsen HL, Schønheyder HC, et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009;137:495-501.
2. Sasaki M, Klapproth JM. The role of bacteria in the pathogenesis of ulcerative colitis. J Signal Transduct 2012;2012:704953.
3. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011;43:246-52.
4. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25.
5. Cooke EM, Ewins SP, Hywel-Jones J, et al. Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut 1974;15:143-6.
6. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780-5.
7. Cucchiara S, Iebba V, Conte MP, et al. The microbiota in inflammatory bowel disease in different age groups. Dig Dis 2009;27:252-8.
8. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007;56:669-75.
9. Martinez-Medina M, Aldeguer X, Lopez-Siles M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis 2009;15:872-82.
10. Jakobsen L, Garneau P, Kurbasic A, et al. Microarray-based detection of extended virulence and antimicrobial resistance gene profiles in phylogroup B2 Escherichia coli of human, meat and animal origin. J Med Microbiol 2011;60(Pt 10):1502-11.
11. Unno N, Fink MP. Intestinal epithelial hyperpermeability. Mechanisms and relevance to disease. Gastroenterol Clin North Am 1998;27:289-307.
12. Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudin-2, -5 and -8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007;56:61-72.
13. Gitter AH, Wullstein F, Fromm M, et al. Epithelial barrier defects in ulcerative colitis: characterization and quanti fication by electrophysiological imaging. Gastroenterology 2001;121:1320-8.
14. Taddei CR, Fasano A, Ferreira AJ, et al. Secreted autotransporter toxin produced by a diffusely adhering Escherichia coli strain causes intestinal damage in animal model assays. FEMS Microbiol Lett 2005;250:263-9.
15. Boisen N, Ruiz-Perez F, Scheutz F, et al. Short report: high prevalence of serine protease autotransporter cytotoxins among strains of enteroaggregative Escherichia coli. Am J Trop Med Hyg 2009;80:294-301.
16. 2+ oscillations in renal epithelial cells. Nature 2000;405:694-7.
17. Songserm T, Zekarias B, van Roozelaar DJ, et al. Experimental reproduction of malabsorption syndrome with different combinations of reovirus, Escherichia coli, and treated homogenates obtained from broilers. Avian Dis 2002;46:87-94.
18. Raimondi F, Kao JP, Kaper JB, et al. Calcium-dependent intestinal chloride secretion by Vibrio parahaemolyticus thermostable direct hemolysin in a rabbit model. Gastroenterology 1995;109:381-6.
19. Hutto DL, Wannemuehler MJ. A comparison of the morphologic effects of Serpulina hyodysenteriae or its beta-hemolysin on the murine cecal mucosa. Vet Pathol 1999;36:412-22.
20. Troeger H, Richter JF, Beutin L, et al. E. coli alpha-hemolysin induces focal leaks in colonic epithelium - a novel mechanism of bacterial translocation. Cell Microbiol 2007;9:2530-40.
21. Günzel D, Florian P, Richter JF, et al. Restitution of single-cell defects in the mouse colon epithelium differs from that of cultured cells. Am J Physiol Reg Integr Comp Physiol 2006;290:R1496-507.
22. Nagy G, Altenhoefer A, Knapp O, et al. Both alpha-haemolysin determinants contribute to full virulence of uropathogenic Escherichia coli strain 536. Microbes Infect 2006;8:2006-12.
23. Diard M, Garry L, Selva M, et al. Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization. J Bacteriol 2010;192:4885-93.
24. Araki A, Kanai T, Ishikura T, et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 2005;40:16-23.
25. Katakura K, Lee J, Rachmilewitz D, et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005;115:695-702.
26. Bürgel N, Bojarski C, Mankertz J, et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002;123:433-43.
27. Bratz K, Bücker R, Gölz G, et al. Experimental infection of weaned piglets with Campylobacter coli -excretion and translocation in a pig colonisation trial. Vet Microbiol 2013;162:136-43.
28. Amann RI, Binder BJ, Olson RJ, et al. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990;56:1919-25.
29. Bartosch S, Fite A, Macfarlane GT, et al. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004;70:3575-81.
30. Sepehri S, Khafipour E, Bernstein CN, et al. Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1451-63.
31. Vingadassalom D, Kazlauskas A, Skehan B, et al. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A 2009;106:6754-9.
32. Wiles TJ, Dhakal BK, Eto DS, et al. Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins. Mol Biol Cell 2008;19:1427-38.
33. Bücker R, Krug SM, Rosenthal R, et al. Aerolysin from Aeromonas hydrophila perturbs tight junction integrity and cell lesion repair in intestinal epithelial HT-29/ B6 cells. J Infect Dis 2011;204:1283-92.
34. Martin FP, Rezzi S, Philippe D, et al. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 de ficient mice. J Proteome Res 2009;8:2376-87.
35. Opal SM, Cross AS, Gemski P, et al. Aerobactin and alpha-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool. J Infect Dis 1990;161:794-6.
36. Jakobsen L, Garneau P, Bruant G, et al. Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis 2012;31:1121-9.
37. Schultsz C, Moussa M, van Ketel R, et al. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol 1997;50:573-9.
38. Schultsz C, Van Den Berg FM, Ten Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999;117:1089-97.
39. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with infl ammatory bowel disease compared with controls. Scand J Gastroenterol 2002;37:1034-41.
40. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in in flammatory bowel disease. Gastroenterology 2002;122:44-54.
41. Vejborg RM, Hancock V, Petersen AM, et al. Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genomics 2011;12:316.